FoxO integration of insulin signaling with glucose and lipid metabolism

Sojin Lee1, H Henry Dong2

  • 1Division of Endocrinology and DiabetesDepartment of Pediatrics, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Insights

Forkhead box O6 (FoxO6) plays a unique role in regulating metabolism and brain function, distinct from other FoxO proteins. Understanding FoxO6 is crucial for addressing diabetes and neurodegenerative diseases.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Neuroscience

Background:

  • The forkhead box O (FoxO) family comprises four mammalian proteins (FoxO1, FoxO3, FoxO4, FoxO6) involved in crucial cellular functions.
  • FoxO proteins regulate insulin/IGF signaling impacting metabolism, growth, differentiation, oxidative stress, senescence, autophagy, and aging.
  • Altered FoxO expression is linked to metabolic diseases, cancer, and lifespan alterations.

Purpose of the Study:

  • To review the distinct role of FoxO6, compared to other FoxO isoforms, in health and disease.
  • To elucidate the unique mechanism of FoxO6 in integrating insulin signaling with hepatic glucose and lipid metabolism.
  • To highlight FoxO6's involvement in neurodegeneration, aging, and its potential as a therapeutic target.

Main Methods:

  • Literature review focusing on FoxO6 function and its contrast with other FoxO isoforms.
  • Analysis of FoxO6's role in insulin signaling pathways.
  • Examination of FoxO6's contribution to metabolic and neurological conditions.

Main Results:

  • FoxO6 exhibits an evolutionarily divergent mechanism in mediating insulin action compared to other FoxO members.
  • Dysregulation of FoxO6 is implicated in the pathogenesis of insulin resistance, obesity, type 2 diabetes, hyperglycemia, and hyperlipidemia.
  • FoxO6 is involved in memory consolidation and contributes to neurodegeneration and aging.

Conclusions:

  • FoxO6 plays a pivotal, yet understudied, role in liver, skeletal muscle, and brain functions.
  • FoxO6 dysregulation contributes significantly to metabolic disorders like diabetes and neurodegenerative diseases.
  • Pharmacological inhibition of FoxO6 presents a potential therapeutic strategy for managing glucose and lipid metabolism in diabetes.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.9K
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.0K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K